4.7 Article

Retinoblastoma-independent regulation of cell proliferation and senescence by the p53-p21 axis in lamin A/C-depleted cells

期刊

AGING CELL
卷 10, 期 5, 页码 789-797

出版社

WILEY-BLACKWELL
DOI: 10.1111/j.1474-9726.2011.00719.x

关键词

E2F; lamin A; muscular dystrophy; p21; p53; senescence

资金

  1. Canadian Cancer Society

向作者/读者索取更多资源

The expression of A-type lamin is downregulated in several cancers, and lamin defects are the cause of several diseases including a form of accelerated aging. We report that depletion of lamin A/C expression in normal human cells leads to a dramatic downregulation of the Rb family of tumor suppressors and a defect in cell proliferation. Lamin A/C-depleted cells exhibited a flat morphology and accumulated markers of cellular senescence. This senescent phenotype was accompanied by engagement of the p53 tumor suppressor and induction of the p53 target gene p21 and was prevented by small hairpin RNAs against p53, p21, or by the oncoprotein Mdm2. The expression of E2F target genes, normally required for cell cycle progression, was downregulated after lamin A/C depletion but restored after the inactivation of p53. A similar senescence response was observed in myoblasts from a patient with a lamin A mutation causing muscular dystrophy. We thus reveal a previously unnoticed mechanism of controlling cell cycle genes expression, which depends on p53 but does not require the retinoblastoma family of tumor suppressors and that can be relevant to understand the pathogenesis of laminopathies and perhaps aging.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cell Biology

Ribosomal protein RPL22/eL22 regulates the cell cycle by acting as an inhibitor of the CDK4-cyclin D complex

Neylen Del Toro, Ana Fernandez-Ruiz, Lian Mignacca, Paloma Kalegari, Marie-Camille Rowell, Sebastian Igelmann, Emmanuelle Saint-Germain, Mehdi Benfdil, Stephane Lopes-Paciencia, Lea Brakier-Gingras, Veronique Bourdeau, Gerardo Ferbeyre, Frederic Lessard

CELL CYCLE (2019)

Article Cell Biology

Estrogen-related receptors are targetable ROS sensors

Mathieu Vernier, Catherine R. Dufour, Shawn McGuirk, Charlotte Scholtes, Xiaojing Li, Guillaume Bourmeau, Hellen Kuasne, Morag Park, Julie St-Pierre, Etienne Audet-Walsh, Vincent Giguere

GENES & DEVELOPMENT (2020)

Review Endocrinology & Metabolism

Aging, senescence and mitochondria: the PGC-1/ERR axis

Mathieu Vernier, Vincent Giguere

Summary: Aging is a degenerative process caused by the accumulation of cellular and tissue lesions, with deregulated mitochondrial function being a central regulator. Research highlights the importance of the PGC-1/ERR axis in age-related mitochondrial deregulation and tissue dysfunction, suggesting pharmacological targeting of this axis may help alleviate the onset of aging and its adverse effects.

JOURNAL OF MOLECULAR ENDOCRINOLOGY (2021)

Article Biochemistry & Molecular Biology

Inhibition of DNMT1 and ERRα crosstalk suppresses breast cancer via derepression ofIRF4

Mathieu Vernier, Shawn McGuirk, Catherine R. Dufour, Liangxinyi Wan, Etienne Audet-Walsh, Julie St-Pierre, Vincent Giguere

ONCOGENE (2020)

Review Oncology

Senescence: A program in the road to cell elimination and cancer

Olga Moiseeva, Jordan Guillon, Gerardo Ferbeyre

Summary: Senescence is a tumor suppressor response that prevents mutated cell proliferation and alerts the immune system, but can be impaired over time, promoting cancer progression. A polyploid barrier and nuclear lamina act as additional safeguards to prevent cancer development.

SEMINARS IN CANCER BIOLOGY (2022)

Editorial Material Cell Biology

Editorial: AMPK and mTOR Beyond Signaling: Emerging Roles in Transcriptional Regulation

Etienne Audet-Walsh, Mathieu Vernier, Benoit Viollet

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Multidisciplinary Sciences

Osteoclasts protect bone blood vessels against senescence through the angiogenin/plexin-B2 axis

Xiaonan Liu, Yu Chai, Guanqiao Liu, Weiping Su, Qiaoyue Guo, Xiao Lv, Peisong Gao, Bin Yu, Gerardo Ferbeyre, Xu Cao, Mei Wan

Summary: The study reveals that glucocorticoids (GCs) disrupt bone development by interfering with osteoclast-secreted angiogenin (ANG), leading to vascular cell aging, impaired angiogenesis, and unbalanced skeletal development.

NATURE COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

Phenylethynylbenzyl-modified biguanides inhibit pancreatic cancer tumor growth

Audrey Hebert, Maxime Parisotto, Marie-Camille Rowell, Alexandra Dore, Ana Fernandez, Guillaume Lefrancois, Paloma Kalegari, Gerardo Ferbeyre, Andreea R. Schmitzer

Summary: Substituted biguanidium salts have shown promising ability to inhibit pancreatic cancer cell growth, with phenylethynyl biguanidium salts exhibiting superior activity in crossing hydrophobic barriers, enhancing mitochondrial accumulation, and anticancer effects. The most active compound, 1b, demonstrated similar mechanisms as metformin but at a much lower concentration, showing significant inhibition of pancreatic cancer xenograft growth in vivo. Existing clinical trial biguanides showed limited activity in comparison.

SCIENTIFIC REPORTS (2021)

Review Cardiac & Cardiovascular Systems

The role of cellular senescence in cardiac disease: basic biology and clinical relevance

Mozhdeh Mehdizadeh, Martin Aguilar, Eric Thorin, Gerardo Ferbeyre, Stanley Nattel

Summary: This review discusses the role of cellular senescence in cardiac disease, outlines therapeutic strategies for targeting senescence, and considers potential implications for improving the management of patients with heart disease. The complex senescence-associated secretory phenotype (SASP) of senescent cells has important effects on cell and tissue biology. Future research is needed to better understand the precise role of senescent cells in various cardiac pathologies and develop strategies for preventing their accumulation.

NATURE REVIEWS CARDIOLOGY (2022)

Article Pharmacology & Pharmacy

Characterization of the impact of MYBBP1A gene and rs3809849 on asparaginase sensitivity and cellular functions

Rachid Abaji, Vincent Roux, Ismahene Reguieg Yssaad, Paloma Kalegari, Vincent Gagne, Romain Gioia, Gerardo Ferbeyre, Christian Beausejour, Maja Krajinovic

Summary: The role of MYBBP1A gene and rs3809849 in pancreatic cancer and lymphoblastic leukemia, as well as their response to asparaginase treatment, were investigated. MYBBP1A was found to play an important role in regulating various cellular functions and its rs3809849 polymorphism was found to have a tissue-specific role in asparaginase treatment response.

PHARMACOGENOMICS (2022)

Article Cell Biology

The mTOR chromatin-bound interactome in prostate cancer

Catherine R. Dufour, Charlotte Scholtes, Ming Yan, Yonghong Chen, Lingwei Han, Ting Li, Hui Xia, Qiyun Deng, Mathieu Vernier, Vincent Giguere

Summary: An increasing number of studies support the direct role of nuclear mTOR in gene regulation and chromatin structure. However, the limited knowledge of chromatin-bound mTOR partners restricts our understanding of how nuclear mTOR controls transcription. This study comprehensively maps the mTOR chromatin-bound interactome in prostate cancer cellular models and identifies a 67-protein interaction network enriched with chromatin modifiers, transcription factors, and SUMOylation machinery. SUMO2/3 and nuclear pore protein NUP210 are among the strongest interactors, while the androgen receptor (AR) is the dominant androgen-inducible mTOR partner. Further investigation reveals the role of NUP210 in mTOR nuclear trafficking, the functional transcriptional module formed by mTOR, AR, and the nucleosome remodeling and deacetylase (NuRD) complex, and the androgen-dependent mTOR-SUMO2/3 promoter-enhancer association.

CELL REPORTS (2022)

Review Oncology

Liquid-Liquid Phase Separation in Cancer Signaling, Metabolism and Anticancer Therapy

Sebastian Igelmann, Frederic Lessard, Gerardo Ferbeyre

Summary: Emerging evidence suggests that the organization of cells into membraneless sub-compartments, known as biological condensates, confers unique properties to cancer cells. Recent research has shown that genetic and epigenetic changes can drive the formation of these condensates, leading to the stable maintenance of cellular states. This review highlights the specific biological condensates in cancer, initiated by mutant oncoproteins, RNA-binding proteins, or lincRNAs, which regulate oncogenic gene expression programs and cancer metabolism. Targeting these oncogenic condensates with effective anticancer drugs could be a promising therapeutic approach.

CANCERS (2022)

Article Biochemistry & Molecular Biology

Zinc controls PML nuclear body formation through regulation of a paralog specific auto-inhibition in SUMO1

Mathieu Lussier-Price, Haytham M. Wahba, Xavier H. Mascle, Laurent Cappadocia, Veronique Bourdeau, Christina Gagnon, Sebastian Igelmann, Kazuyasu Sakaguchi, Gerardo Ferbeyre, James G. Omichinski

Summary: The N-terminal region of SUMO proteins plays an auto-inhibition role in promoting PML-NB formation, and this auto-inhibition can be relieved by zinc, leading to increased PML-NB formation within cells.

NUCLEIC ACIDS RESEARCH (2022)

Article Oncology

SOCS1 Deficiency Promotes Hepatocellular Carcinoma via SOCS3-Dependent CDKN1A Induction and NRF2 Activation

Md Gulam Musawwir Khan, Nadia Boufaied, Mehdi Yeganeh, Rajani Kandhi, Stephanie Petkiewicz, Ankur Sharma, Akihiko Yoshimura, Gerardo Ferbeyre, David P. Labbe, Sheela Ramanathan, Subburaj Ilangumaran

Summary: The SOCS1 protein protects liver cells from becoming cancerous and its deficiency increases susceptibility to liver cancer. CDKN1A is a protein that can protect against liver cancer but under certain circumstances, it can promote cancer growth. Our findings show that SOCS1 suppresses the expression of CDKN1A, preventing liver cells from withstanding the stress associated with cancer growth. This pathway could be targeted for therapeutic strategies in SOCS1-deficient liver cancers.

CANCERS (2023)

Article Oncology

The NAMPT Inhibitor FK866 Increases Metformin Sensitivity in Pancreatic Cancer Cells

Maxime Parisotto, Nhung Vuong-Robillard, Paloma Kalegari, Thulaj Meharwade, Loick Joumier, Sebastian Igelmann, Veronique Bourdeau, Marie-Camille Rowell, Michael Pollak, Mohan Malleshaiah, Andreea Schmitzer, Gerardo Ferbeyre

Summary: The use of metformin as a single antitumor agent has been disappointing, but combining it with the NAD biosynthesis inhibitor FK866 has shown superior antitumor activity. This study reveals the mechanism of metformin's antitumor actions and suggests that targeting mitochondria and NAD biosynthesis can lead to effective antitumor therapies.

CANCERS (2022)

暂无数据